Published by ODA3 InstituteDocs / GAISSF™ / Sector guidance
GAISSF™ Pharmaceutical Sector Implementation Guide
ID GAISSF-SEC-049
Framework GAISSF™ Type Sector guidance
What it coversGAISSF-SEC-049 translates each authoritative GAISSF control into sector implementation considerations while preserving the distinction between normative requirements and informative guidance.
Use it whenThis guide supports CISOs, security architects, AI governance leads, quality and validation leaders, pharmacovigilance, clinical operations, regulatory affairs, manufacturing, laboratory, privacy, legal, audit and risk functions.
Scope and limitsGAISSF controls do not replace GxP quality-system obligations, pharmacovigilance or clinical-trial regulation, product-conformity obligations, legal review or organization-specific validation.
Revision history
| Date (as stated) | Event | What changed |
|---|---|---|
| Not assigned | Publication | Published as v1.1Source: Page metadata (/sectors/sec-049-pharmaceutical/) |
| 5 October 2026 | Document revision | Draft for Publication issued; UAIF™ mark correctedSource: GAISSF-SEC-049_Pharmaceutical_Sector_Implementation_Guide_v1.0.pdf |
Website record last updated 7 October 2026. This is the web page, not the document.
More from GAISSF™
| SEC-047 | GAISSF™ Telecommunications Sector Implementation Guide |
| NOR-001 | GAISSF™ Framework Standard |
| NOR-002 | GAISSF™ Executive Summary |
| NOR-003 | GAISSF™ Quick Start Guide |
Cite this document
ODA3 Institute. GAISSF™ Pharmaceutical Sector Implementation Guide (GAISSF-SEC-049), v1.0. Published 1 July 2026. docs.oda3.org/documents/sec-049/
ODA3 Institute. GAISSF™ Pharmaceutical Sector Implementation Guide (GAISSF-SEC-049), v1.0. Published 1 July 2026. docs.oda3.org/documents/sec-049/